AIRLINK 72.59 Increased By ▲ 3.39 (4.9%)
BOP 4.99 Increased By ▲ 0.09 (1.84%)
CNERGY 4.29 Increased By ▲ 0.03 (0.7%)
DFML 31.71 Increased By ▲ 0.46 (1.47%)
DGKC 80.90 Increased By ▲ 3.65 (4.72%)
FCCL 21.42 Increased By ▲ 1.42 (7.1%)
FFBL 35.19 Increased By ▲ 0.19 (0.54%)
FFL 9.33 Increased By ▲ 0.21 (2.3%)
GGL 9.82 Increased By ▲ 0.02 (0.2%)
HBL 112.40 Decreased By ▼ -0.36 (-0.32%)
HUBC 136.50 Increased By ▲ 3.46 (2.6%)
HUMNL 7.14 Increased By ▲ 0.19 (2.73%)
KEL 4.35 Increased By ▲ 0.12 (2.84%)
KOSM 4.35 Increased By ▲ 0.10 (2.35%)
MLCF 37.67 Increased By ▲ 1.07 (2.92%)
OGDC 137.75 Increased By ▲ 4.88 (3.67%)
PAEL 23.41 Increased By ▲ 0.77 (3.4%)
PIAA 24.55 Increased By ▲ 0.35 (1.45%)
PIBTL 6.63 Increased By ▲ 0.17 (2.63%)
PPL 125.05 Increased By ▲ 8.75 (7.52%)
PRL 26.99 Increased By ▲ 1.09 (4.21%)
PTC 13.32 Increased By ▲ 0.24 (1.83%)
SEARL 52.70 Increased By ▲ 0.70 (1.35%)
SNGP 70.80 Increased By ▲ 3.20 (4.73%)
SSGC 10.54 No Change ▼ 0.00 (0%)
TELE 8.33 Increased By ▲ 0.05 (0.6%)
TPLP 10.95 Increased By ▲ 0.15 (1.39%)
TRG 60.60 Increased By ▲ 1.31 (2.21%)
UNITY 25.10 Decreased By ▼ -0.03 (-0.12%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 7,566 Increased By 157.7 (2.13%)
BR30 24,786 Increased By 749.4 (3.12%)
KSE100 71,902 Increased By 1235.2 (1.75%)
KSE30 23,595 Increased By 371 (1.6%)

imageSHANGHAI: A Shanghai health official has been arrested on suspicion of crime, local authorities said, with state media linking his downfall to the bribery scandal surrounding British drugmaker GlaxoSmithKline.

Huang Fengping, who was suspended earlier this month as deputy director of the Shanghai Municipal Commission for Health and Family Planning, was arrested Wednesday for allegedly committing a crime, the Shanghai Municipal People's Prosecution Service said in a one-sentence statement.

It gave no further details, but state media have reported that Huang allegedly accepted bribes in his earlier positions at local hospitals and might be involved in the GlaxoSmithKline (GSK) commercial bribery case.

"Huang Fengping has close relatives working at GlaxoSmithKline and some family members have migrated to Canada," an unnamed source told the 21st Century Business Herald newspaper earlier this month.

Chinese authorities said in July that GSK staff had bribed government officials, pharmaceutical industry groups, hospitals and doctors to help sales of their products and increase prices for drugs.

State media quoted a public security bureau official as saying that GSK had transferred around 3 billion yuan ($490 million) to more than 700 travel agencies and consultancy firms since 2007.

Police have detained four top GSK executives as well as a British fraud investigator, Peter Humphrey, whose company has worked for GSK.

GSK says it is concerned about allegations of misconduct and is co-operating with the investigation.

The inquiry was launched at a time when China launched sweeping probes into alleged malpractice by foreign firms in various sectors, and against the backdrop of an anti-graft campaign backed by President Xi Jinping to root out corrupt officials from the party.

Huang has been removed from the list of leaders on the website of the local health commission.

Comments

Comments are closed.